Lamivudine

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26015 publications

Structural and Mechanistic Basis of F227C-Mediated Hypersusceptibility to Islatravir in HIV-1 Reverse Transcriptase.

Structural and Mechanistic Basis of F227C-Mediated Hypersusceptibility to Islatravir in HIV-1 Reverse Transcriptase.

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026

Intestinal Deglycosylation Activates Saikosaponins as Potent, Selective UGT2B7/2B15 Inhibitors: Structural Basis and Implications for Herb-Drug Interactions.

Intestinal Deglycosylation Activates Saikosaponins as Potent, Selective UGT2B7/2B15 Inhibitors: Structural Basis and Implications for Herb-Drug Interactions.

Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: June 20, 2026

Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature.

Long-acting injectable cabotegravir/rilpivirine in a pregnant woman living with HIV with hyperemesis gravidarum:a case report and review of literature.

Journal: International journal of STD & AIDS
Published: June 17, 2026

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV.

Effects of malaria intermittent preventive treatment with dihydroartemisinin-piperaquine on antiretroviral drug concentrations in African pregnant women living with HIV.

Journal: Antimicrobial agents and chemotherapy
Published: June 12, 2026

First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapy.

First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapy.

Journal: Research square
Published: June 12, 2026

Efficacy and safety of doravirine/lamivudine/tenofovir as initial treatment for people living with HIV in China.

Efficacy and safety of doravirine/lamivudine/tenofovir as initial treatment for people living with HIV in China.

Journal: Antimicrobial agents and chemotherapy
Published: June 04, 2026

Retrotransposons as both "architects" and "saboteurs" in the nervous system.

Retrotransposons as both "architects" and "saboteurs" in the nervous system.

Journal: Advances in genetics
Published: June 01, 2026

Efavirenz Mitigates Dyslipidemia and Attenuates Ulcerative Colitis through Gut Microbiota Modulation.

Efavirenz Mitigates Dyslipidemia and Attenuates Ulcerative Colitis through Gut Microbiota Modulation.

Journal: ACS infectious diseases
Published: June 01, 2026

Erythrovirus-B19-Induced Pure Red Cell Aplasia Revealing Untreated HIV Infection.

Erythrovirus-B19-Induced Pure Red Cell Aplasia Revealing Untreated HIV Infection.

Journal: The American journal of case reports
Published: May 19, 2026

Neonatal Lactic Acidosis Associated With Antiretroviral Exposure: A Case Report.

Neonatal Lactic Acidosis Associated With Antiretroviral Exposure: A Case Report.

Journal: Cureus
Published: May 18, 2026

Efficacy and metabolic outcomes of switching from an INSTI-based triple-drug regimen to dolutegravir/lamivudine in treatment-experienced HIV-1-infected patients: a 48-week real-world study.

Efficacy and metabolic outcomes of switching from an INSTI-based triple-drug regimen to dolutegravir/lamivudine in treatment-experienced HIV-1-infected patients: a 48-week real-world study.

Journal: Annals of medicine
Published: May 13, 2026

Pharmacogenomics of current antiretroviral drugs.

Pharmacogenomics of current antiretroviral drugs.

Journal: Pharmacogenomics
Published: May 12, 2026
Showing 1-12 of 26,015

Last Updated: 06/30/2026